These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 7910437

  • 21. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
    Ganzini L, Casey DE, Hoffman WF, McCall AL.
    Arch Intern Med; 1993 Jun 28; 153(12):1469-75. PubMed ID: 8512437
    [Abstract] [Full Text] [Related]

  • 22. Prevalence of tardive dyskinesia.
    Tepper SJ, Haas JF.
    J Clin Psychiatry; 1979 Dec 28; 40(12):508-16. PubMed ID: 40964
    [Abstract] [Full Text] [Related]

  • 23. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia.
    Sirota P, Mosheva T, Shabtay H, Giladi N, Korczyn AD.
    Am J Psychiatry; 2000 Feb 28; 157(2):287-9. PubMed ID: 10671405
    [Abstract] [Full Text] [Related]

  • 24. Low incidence of persistent tardive dyskinesia in elderly patients with dementia treated with risperidone.
    Jeste DV, Okamoto A, Napolitano J, Kane JM, Martinez RA.
    Am J Psychiatry; 2000 Jul 28; 157(7):1150-5. PubMed ID: 10873925
    [Abstract] [Full Text] [Related]

  • 25. Incidence of tardive dyskinesia and tardive dystonia in African Caribbean patients on long-term antipsychotic treatment: the Curaçao extrapyramidal syndromes study V.
    van Harten PN, Hoek HW, Matroos GE, van Os J.
    J Clin Psychiatry; 2006 Dec 28; 67(12):1920-7. PubMed ID: 17194270
    [Abstract] [Full Text] [Related]

  • 26. Informing patients about tardive dyskinesia: four-year follow up of a trial of patient education.
    Chaplin R, Timehin C.
    Aust N Z J Psychiatry; 2002 Feb 28; 36(1):99-103. PubMed ID: 11929445
    [Abstract] [Full Text] [Related]

  • 27. Tardive dyskinesia.
    Casey DE.
    West J Med; 1990 Nov 28; 153(5):535-41. PubMed ID: 1979705
    [Abstract] [Full Text] [Related]

  • 28. Factors in the development of severe forms of tardive dyskinesia.
    Yassa R, Nair NP, Iskander H, Schwartz G.
    Am J Psychiatry; 1990 Sep 28; 147(9):1156-63. PubMed ID: 1974745
    [Abstract] [Full Text] [Related]

  • 29. Tardive dyskinesia and glucid metabolism.
    Brousse G, Meary A, Mouret J, Blanc O, Hueber T, Lemoine P, Llorca PM, Lachaux B.
    Hum Psychopharmacol; 2007 Aug 28; 22(6):373-80. PubMed ID: 17579925
    [Abstract] [Full Text] [Related]

  • 30. Comparison of severe and mild tardive dyskinesia: implications for etiology.
    Gardos G, Cole JO, Schniebolk S, Salomon M.
    J Clin Psychiatry; 1987 Sep 28; 48(9):359-62. PubMed ID: 2887550
    [Abstract] [Full Text] [Related]

  • 31. Buspirone in the treatment of tardive dyskinesia.
    Moss LE, Neppe VM, Drevets WC.
    J Clin Psychopharmacol; 1993 Jun 28; 13(3):204-9. PubMed ID: 8102622
    [Abstract] [Full Text] [Related]

  • 32. The prevalence of tardive dyskinesia in geropsychiatric outpatients.
    Chacko RC, Root L, Marmion J, Molinari V, Adams GL.
    J Clin Psychiatry; 1985 Feb 28; 46(2):55-7. PubMed ID: 2857168
    [Abstract] [Full Text] [Related]

  • 33. Relationship of awareness of dyskinesia in schizophrenia to insight into mental illness.
    Arango C, Adami H, Sherr JD, Thaker GK, Carpenter WT.
    Am J Psychiatry; 1999 Jul 28; 156(7):1097-9. PubMed ID: 10401460
    [Abstract] [Full Text] [Related]

  • 34. Effects of antipsychotic treatment on tardive dyskinesia: a 6-month evaluation of patients from the European Schizophrenia Outpatient Health Outcomes (SOHO) Study.
    Tenback DE, van Harten PN, Slooff CJ, Belger MA, van Os J, SOHO Study Group.
    J Clin Psychiatry; 2005 Sep 28; 66(9):1130-3. PubMed ID: 16187770
    [Abstract] [Full Text] [Related]

  • 35. Prospective study of tardive dyskinesia incidence in the elderly.
    Saltz BL, Woerner MG, Kane JM, Lieberman JA, Alvir JM, Bergmann KJ, Blank K, Koblenzer J, Kahaner K.
    JAMA; 1991 Nov 06; 266(17):2402-6. PubMed ID: 1681122
    [Abstract] [Full Text] [Related]

  • 36. A review of 32 cases of tardive dystonia.
    Wojcik JD, Falk WE, Fink JS, Cole JO, Gelenberg AJ.
    Am J Psychiatry; 1991 Aug 06; 148(8):1055-9. PubMed ID: 1677236
    [Abstract] [Full Text] [Related]

  • 37. Changes in negative symptoms and the risk of tardive dyskinesia: a longitudinal study. UK700 Group.
    van Os J, Walsh E, van Horn E, Tattan T, Bale R, Thompson SG.
    Acta Psychiatr Scand; 2000 Apr 06; 101(4):300-6. PubMed ID: 10782550
    [Abstract] [Full Text] [Related]

  • 38. Evidence that early extrapyramidal symptoms predict later tardive dyskinesia: a prospective analysis of 10,000 patients in the European Schizophrenia Outpatient Health Outcomes (SOHO) study.
    Tenback DE, van Harten PN, Slooff CJ, van Os J.
    Am J Psychiatry; 2006 Aug 06; 163(8):1438-40. PubMed ID: 16877660
    [Abstract] [Full Text] [Related]

  • 39. Screening for tardive dyskinesia.
    Munetz MR, Schulz SC.
    J Clin Psychiatry; 1986 Feb 06; 47(2):75-7. PubMed ID: 2867994
    [Abstract] [Full Text] [Related]

  • 40. Treatment of tardive dyskinesia with vitamin E.
    Egan MF, Hyde TM, Albers GW, Elkashef A, Alexander RC, Reeve A, Blum A, Saenz RE, Wyatt RJ.
    Am J Psychiatry; 1992 Jun 06; 149(6):773-7. PubMed ID: 1350428
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.